GB201321628D0 - Treatment of disease - Google Patents
Treatment of diseaseInfo
- Publication number
- GB201321628D0 GB201321628D0 GB201321628A GB201321628A GB201321628D0 GB 201321628 D0 GB201321628 D0 GB 201321628D0 GB 201321628 A GB201321628 A GB 201321628A GB 201321628 A GB201321628 A GB 201321628A GB 201321628 D0 GB201321628 D0 GB 201321628D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- disease
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201321628A GB201321628D0 (en) | 2013-12-06 | 2013-12-06 | Treatment of disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201321628A GB201321628D0 (en) | 2013-12-06 | 2013-12-06 | Treatment of disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201321628D0 true GB201321628D0 (en) | 2014-01-22 |
Family
ID=50000332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201321628A Ceased GB201321628D0 (en) | 2013-12-06 | 2013-12-06 | Treatment of disease |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201321628D0 (en) |
-
2013
- 2013-12-06 GB GB201321628A patent/GB201321628D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287516A (en) | Therapeutic uses of empagliflozin | |
HRP20190101T1 (en) | Therapeutic uses of empagliflozin | |
IL243976B (en) | Kdm1a inhibitors for the treatment of disease | |
HK1213818A1 (en) | Therapeutic uses of empagliflozin | |
EP2958936A4 (en) | Methods and compositions for treatment of forbes-cori disease | |
HUE064634T2 (en) | Treatment of cardiovascular diseases | |
LT2981271T (en) | Therapeutic uses of empagliflozin | |
HK1219653A1 (en) | Methods for the treatment of mitochondrial disease | |
GB201304872D0 (en) | Treatment | |
GB201607581D0 (en) | Treatment of cancer | |
HK1220127A1 (en) | Treatment of autoimmune diseases | |
HK1232118A1 (en) | Treatment of cancer | |
GB201307310D0 (en) | Treatment | |
GB201321628D0 (en) | Treatment of disease | |
GB201320014D0 (en) | Treatment of cardiovascular disease | |
GB201322347D0 (en) | Treatment of cancer | |
GB201318742D0 (en) | Treatment of cancer | |
GB201308529D0 (en) | Treatment of cancer | |
GB201305020D0 (en) | Treatment of cancer | |
GB201322346D0 (en) | Combination treatment of cancer | |
GB201204645D0 (en) | Treatment of disease | |
GB201321115D0 (en) | Treatment | |
GB201309238D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |